---
ver: rpa2
title: 'ToxBench: A Binding Affinity Prediction Benchmark with AB-FEP-Calculated Labels
  for Human Estrogen Receptor Alpha'
arxiv_id: '2507.08966'
source_url: https://arxiv.org/abs/2507.08966
tags:
- binding
- toxbench
- affinity
- prediction
- ligand
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: "This paper introduces ToxBench, the first large-scale benchmark\
  \ dataset for binding affinity prediction built using physics-based AB-FEP calculations\
  \ on human estrogen receptor alpha (ER\u03B1). The dataset includes 8,770 ER\u03B1\
  -ligand complexes with high-fidelity binding free energies, validated against experimental\
  \ data with 1.75 kcal/mol RMSE."
---

# ToxBench: A Binding Affinity Prediction Benchmark with AB-FEP-Calculated Labels for Human Estrogen Receptor Alpha

## Quick Facts
- **arXiv ID**: 2507.08966
- **Source URL**: https://arxiv.org/abs/2507.08966
- **Reference count**: 36
- **Primary result**: Introduces ToxBench dataset with 8,770 ERα-ligand complexes using AB-FEP calculations and proposes DualBind model achieving 0.844 Pearson correlation and 2.392 kcal/mol RMSE

## Executive Summary
This paper presents ToxBench, the first large-scale benchmark dataset for binding affinity prediction built using physics-based alchemical free energy perturbation (AB-FEP) calculations on human estrogen receptor alpha (ERα). The dataset comprises 8,770 high-quality ERα-ligand complexes with binding free energies validated against experimental data with 1.75 kcal/mol RMSE. To address the challenge of accurate yet efficient affinity prediction, the authors introduce DualBind, a deep learning model that combines supervised mean squared error (MSE) loss with unsupervised denoising score matching (DSM) loss. Experimental results demonstrate that DualBind achieves state-of-the-art performance on ToxBench while providing 106x faster predictions compared to AB-FEP calculations, making it promising for high-throughput drug discovery applications.

## Method Summary
The authors developed ToxBench by calculating binding free energies for 8,770 ERα-ligand complexes using alchemical free energy perturbation (AB-FEP) methods, which provide physics-based, high-fidelity labels for training and benchmarking affinity prediction models. The DualBind model architecture combines supervised learning with MSE loss and unsupervised learning through denoising score matching (DSM) loss, creating a hybrid approach that leverages both labeled affinity data and unlabeled structural information. The model was trained and evaluated on the ToxBench dataset, demonstrating superior performance compared to baseline models while maintaining computational efficiency that enables rapid screening of large compound libraries.

## Key Results
- DualBind achieves 0.844 Pearson correlation and 2.392 kcal/mol RMSE on ToxBench
- 106x speedup compared to AB-FEP calculations while maintaining high accuracy
- Validated against experimental data with 1.75 kcal/mol RMSE for AB-FEP-calculated labels

## Why This Works (Mechanism)
The success of DualBind stems from its hybrid training approach that combines supervised and unsupervised learning objectives. The supervised MSE loss ensures accurate prediction of binding affinities using the high-quality AB-FEP labels, while the unsupervised DSM loss enables the model to learn rich structural representations from unlabeled data, improving generalization. The physics-based AB-FEP calculations provide reliable ground truth labels that capture the complex thermodynamic interactions governing molecular binding, creating a high-quality benchmark dataset that enables robust model training and evaluation.

## Foundational Learning

**Alchemical Free Energy Perturbation (AB-FEP)**: A physics-based computational method for calculating binding free energies by gradually transforming one molecular state to another. *Why needed*: Provides high-fidelity, physics-based labels for training binding affinity prediction models. *Quick check*: Verify AB-FEP calculations match experimental binding affinities within acceptable error margins.

**Denoising Score Matching (DSM)**: An unsupervised learning technique that trains models to estimate the gradient of the data probability density function. *Why needed*: Enables learning from unlabeled structural data to improve model generalization. *Quick check*: Confirm DSM loss improves model performance on unseen data.

**Binding Affinity Prediction**: The task of estimating the strength of interaction between a protein and a ligand, typically measured in kcal/mol. *Why needed*: Central to drug discovery and understanding molecular interactions. *Quick check*: Validate predicted affinities correlate with experimental measurements.

**Deep Learning for Molecular Properties**: Using neural networks to learn complex relationships between molecular structures and their properties. *Why needed*: Enables rapid, accurate prediction of molecular properties from structural data. *Quick check*: Ensure model generalizes beyond training data to new molecular structures.

## Architecture Onboarding

**Component Map**: Molecular Structures -> DualBind Model (MSE + DSM Losses) -> Binding Affinity Predictions

**Critical Path**: Input molecular structures → Feature extraction → Dual loss computation (MSE + DSM) → Affinity prediction output

**Design Tradeoffs**: The hybrid supervised/unsupervised approach balances accuracy with generalization, but introduces complexity in training and hyperparameter tuning. The physics-based labels ensure high quality but limit dataset diversity to a single protein target.

**Failure Signatures**: Poor performance on protein targets outside ERα family, overfitting to specific ligand scaffolds present in training data, or sensitivity to molecular representation choices.

**First Experiments**:
1. Test DualBind on ERα-ligand complexes not included in the ToxBench training set
2. Compare performance with and without DSM loss component
3. Evaluate computational speedup and accuracy trade-off against pure AB-FEP calculations

## Open Questions the Paper Calls Out
None

## Limitations
- Dataset focuses exclusively on human estrogen receptor alpha, limiting generalizability
- Claims of being "first large-scale benchmark" should be tempered given other affinity prediction benchmarks
- Unsupervised DSM loss may introduce training complexities not fully explored

## Confidence

| Claim | Confidence Level |
|-------|------------------|
| AB-FEP dataset creation and DualBind model development | High |
| State-of-the-art performance on ToxBench | High |
| Drug discovery impact and generalizability | Medium |

## Next Checks
1. Test DualBind on binding affinity prediction tasks for other protein targets beyond ERα to assess generalizability
2. Conduct ablation studies to quantify the contribution of the DSM loss component versus the supervised MSE loss
3. Evaluate the model's performance on experimentally-measured binding affinities not used in training to verify real-world applicability